A Phase 1, Randomized, Open-label, Parallel-design Study to Compare Single-dose Pharmacokinetics of Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
Phase of Trial: Phase I
Latest Information Update: 08 Apr 2015
Price : $35 *
At a glance
- Drugs Ustekinumab (Primary)
- Indications Atopic dermatitis; Crohn's disease; Palmoplantar pustulosis; Primary biliary cirrhosis; Psoriasis; Rheumatoid arthritis; Sarcoidosis
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 05 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Aug 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 13 Jun 2014 New trial record